Defining risk factors for red man syndrome in children and adults

Pediatric Infectious Disease Journal

Volumn 31, Issue 5, 2012, Pages 464-468

  Myers, Angela L ^a   Gaedigk, Andrea ^a   Dai, Hongying ^a   James, Laura P ^b   Jones, Bridgette L ^a   Neville, Kathleen A ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Histamine; Red man syndrome; Single nucleotide polymorphisms; Vancomycin

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); ANTIHISTAMINIC AGENT; HISTAMINE; VANCOMYCIN;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AFRICAN AMERICAN; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; FEMALE; FLUSHING; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HISTAMINE METABOLISM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PRURITUS; RASH; RED MAN SYNDROME; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; AMINE OXIDASE (COPPER-CONTAINING); CHILD; CHILD, PRESCHOOL; ERYTHEMA; EXANTHEMA; FEMALE; FLUSHING; HISTAMINE; HOSPITALIZATION; HUMANS; INFANT; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRURITUS; RISK FACTORS; SYNDROME; VANCOMYCIN; YOUNG ADULT;

EID: 84860236045     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31824e10d7     Document Type: Article

References (29)

1. Levine DP. Vancomycin: a history. Clin Infect Dis. 2006;42 (suppl 1):S5-12.
2. Wang G, Hindler JF, Ward KW, et al. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol. 2006;44:3883-3886.
3. Wallace MR, Mascola JR, Oldfield EC 3rd. Red man syndrome: incidence, etiology, and prophylaxis. J Infect Dis. 1991;164:1180-1185.
4. O'Sullivan TL, Ruffing MJ, Lamp KC, et al. Prospective evaluation of red man syndrome in patients receiving vancomycin. J Infect Dis. 1993;168: 773-776.
5. Rybak MJ, Bailey EM, Warbasse LH. Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin. Antimicrob Agents Chemother. 1992;36:1204-1207.
6. Levy M, Koren G, Dupuis L, et al. Vancomycin-induced red man syndrome. Pediatrics. 1990;86:572-580.
7. Odio C, Mohs E, Sklar FH, et al. Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures. Am J Dis Child. 1984;138:17-19.
8. Schaad UB, McCracken GH Jr, Nelson JD. Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr. 1980;96:119-126.
9. Fujita K, Murono K, Yoshikawa M, et al. [Intravenous vancomycin treatment in children; its clinical usefulness and serum concentration monitoring]. Jpn J Antibiot. 1993;46:505-510.
10. Le J, Nguyen T, Law AV, et al. Adverse drug reactions among children over a 10-year period. Pediatrics. 2006;118:555-562.
11. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:285-292.
12. Toyoguchi T, Ebihara M, Ojima F, et al. Histamine release induced by antimicrobial agents and effects of antimicrobial agents on vancomycininduced histamine release from rat peritoneal mast cells. J Pharm Pharmacol. 2000;52:327-331.
13. Sahai J, Healy DP, Shelton MJ, et al. Comparison of vancomycin-and teicoplanin-induced histamine release and "red man syndrome". Antimicrob Agents Chemother. 1990;34:765-769.
14. Polk RE, Healy DP, Schwartz LB, et al. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis. 1988;157:502-507.
15. Petersen J, Raithel M, Schwelberger HG. Characterisation of functional polymorphisms of the human diamine oxidase gene. Inflamm Res. 2005;54 Suppl 1:S58-S59.
16. Raithel M, Matek M, Baenkler HW, et al. Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy. Int Arch Allergy Immunol. 1995;108:127-133.
17. Yan L, Galinsky RE, Bernstein JA, et al. Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics. 2000;10:261-266.
18. Barnes PJ, Chung KF, Page CP. Inflammatory mediators and asthma. Pharmacol Rev. 1988;40:49-84.
19. Maslinski C. Histamine and its metabolism in mammals. Part II: Catabolism of histamine and histamine liberation. Agents Actions. 1975;5:183-225.
20. Chen GL, Wang H, Wang W, et al. Histamine N-methyltransferase gene polymorphisms in Chinese and their relationship with enzyme activity in erythrocytes. Pharmacogenetics. 2003;13:389-397.
21. Garce-Marte E, Ayuso P, Mart́ez C, et al. Histamine pharmacogenomics. Pharmacogenomics. 2009;10:867-883.
22. Choi JH, Kim SH, Suh CH, et al. Polymorphisms of high-affinity IgE receptor and histamine-related genes in patients with ASA-induced urticaria/angioedema. J Korean Med Sci. 2005;20:367-372.
23. Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov. 2008;7:41-53.
24. Feudtner C, Hays RM, Haynes G, et al. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics. 2001;107:E99.
25. Kononenko I, Sikonja, MR. Theoretical and empirical analysis of ReliefF and RReliefF. Mach Learn J. 2003;53:23-69.
26. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003;19:376-382.
27. Scadding GW, Scadding GK. Recent advances in antileukotriene therapy. Curr Opin Allergy Clin Immunol. 2010;10:370-376.
28. Gupta MA, Guptat AK. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol. 2001;15:512-518.
29. Healy DP, Sahai JV, Fuller SH, et al. Vancomycin-induced histamine release and "red man syndrome": comparison of 1-and 2-hour infusions. Antimicrob Agents Chemother. 1990;34:550-554.